Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Ivy Farm Technologies Limited has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 distinct examiners and 1 distinct art unit. ZHU, JIANJIAN is the busiest examiner, with 1 pending matter.
The shared art unit provides a common technical setting, but the two examiners create separate prosecution paths. Counsel can use the common unit context to support consistent terminology while examining each action for its own treatment of biological or pharmaceutical claim limitations.
The busiest-examiner field identifies 1 pending matter, so no concentration with one reviewer is shown. A coordinated response strategy should preserve common disclosure positions, while adapting amendments and evidence to the specific rejection in each application.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZHU, JIANJIAN | 1 | 58.1% | +82.5% |
| EBBINGHAUS, BRIANA NOEL | 1 | 59.7% | +63.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18837175 | BIOREACTOR | ZHU, JIANJIAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18837175 | BIOREACTOR | ZHU, JIANJIAN | — |
| 18837150 | CELL CULTURE METHOD, SUBSTRATE ASSEMBLY, BIOREACTOR AND ARTIFICIAL MEAT PRODUCT | EBBINGHAUS, BRIANA NOEL | — |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18837175 | BIOREACTOR | ZHU, JIANJIAN | — | §102§112 | Non-Final OA | — | Pending | Aug 08, 2024 |
| 18837150 | CELL CULTURE METHOD, SUBSTRATE ASSEMBLY, BIOREACTOR AND ARTIFICIAL MEAT PRODUCT | EBBINGHAUS, BRIANA NOEL | 1632 | §102§103§112DP | Non-Final OA | — | Pending | Aug 08, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialIvy Farm Technologies Limited has 2 pending office actions as of October 2026, spread across 1 art units and 2 examiners.
Jianjian Zhu has the most, with 1 of Ivy Farm Technologies Limited's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
